Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
Open Access
- 12 December 2012
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 5 (2) , 621-626
Abstract
The issue of delayed neurological damage as a result of treatment is becoming increasingly important now that an increased number of children survive treatment for acute lymphoblastic leukemia (ALL). Following modification of the treatment protocols, severe symptomatic late effects are rare, and most adverse effects are detected by sensitive imaging methods such as magnetic resonance imaging (MRI) or by neuropsychological testing. In this study we aimed to determine the prevalence and characteristics of late central nervous system (CNS) damage by MRI and clinical examination in children treated for ALL. A cross-sectional study was carried out at the pediatric oncology unit of Zagazig University, Egypt, and included 25 patients who were consecutively enrolled and treated according to the modified Children’s Cancer Group (CCG) 1991 protocol for standard risk ALL and the modified CCG 1961 protocol for high-risk ALL and who had survived more than 5 years from the diagnosis. All relevant data were collected from patients’ medical records; particularly the data concerning the initial clinical presentation and initial brain imaging. All patients were subjected to thorough history and full physical examination with special emphasis on the neurological system. MRI of the brain was performed for all patients. The mean age of patients was 6.9±3.04 years at diagnosis and was 12.9±3.2 years at the time of study. The patients comprised 14 boys and 11 girls. Abnormal MRI findings were detected in six patients (24%). They were in the form of leukoencephalopathy in two patients (8%), brain atrophy in two patients (8%), old infarct in one patient (4%) and old hemorrhage in one patient (4%). The number of abnormal MRI findings was significantly higher in high-risk patients, patients who had CNS manifestations at diagnosis and patients who had received cranial irradiation. We concluded that cranial irradiation is associated with higher incidence of MRI changes in children treated for ALL. Limitation of cranial irradiation to selected patients contributed to a lower incidence of neurological complications in our study. MRI is a sensitive radiological tool to detect structural changes in children treated for ALL, even in asymptomatic cases.Keywords
This publication has 19 references indexed in Scilit:
- Evaluation of the Late Effects of CNS Prophylactic Treatment in Childhood Acute Lymphoblastic Leukemia (ALL) Using Magnetic Resonance Spectroscopy2009
- Treatment of pediatric acute lymphoblastic leukemiaHaematologica, 2008
- Mechanisms of radiation-induced brain toxicity and implications for future clinical trialsJournal of Neuro-Oncology, 2008
- Acute and long-term neurologic complications in children with acute lymphoblastic leukemiaThe Turkish Journal of Pediatrics, 2006
- Treatment of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2006
- Asymptomatic Radiation-induced Telangiectasia in Children after Cranial Irradiation: Frequency, Latency, and Dose RelationRadiology, 2004
- Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periodsBritish Journal of Haematology, 2000
- Outcome after first relapse in children with acute lymphoblastic leukemia: A population‐based study of 315 patients from the nordic society of pediatric hematology and oncology (NOPHO)Medical and Pediatric Oncology, 1995
- Reversible Treatment-Related LeukoencephalopathyJournal of Child Neurology, 1989
- PRESYMPTOMATIC CENTRAL NERVOUS SYSTEM THERAPY IN PREVIOUSLY UNTREATED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA: COMPARISON OF 1800 RAD AND 2400 RADThe Lancet, 1981